Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD

Veterinary Parasitology

Volumn 145, Issue 3-4, 2007, Pages 287-296

  Lopez Aban J ^a   Casanueva, P ^a   Nogal, J ^b   Arias, M ^c   Morrondo, P ^c   Diez Banos P ^c   Hillyer, G V ^d   Martinez Fernandez A R ^b   Muro, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Epidemiology and Zoonoses   (Spain)

^d UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

FABP; Fasciola hepatica; Immunomodulator; Polypodium leucotomos; Vaccine

Indexed keywords

ADJUVANT; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOMODULATING AGENT; OIL; PARASITE ANTIGEN; PROTOZOAL VACCINE; RECOMBINANT PROTEIN; SAPONIN DERIVATIVE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMULSION; FASCIOLA HEPATICA; FASCIOLIASIS; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; LIVER INJURY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; QUILLAJA; SHEEP; SURVIVAL RATE; TREATMENT OUTCOME; VACCINATION; WEIGHT GAIN;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; FASCIOLA HEPATICA; FASCIOLIASIS; FATTY ACID-BINDING PROTEINS; FEMALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SHEEP; SHEEP DISEASES; TIME FACTORS; VACCINES;

ANIMALIA; FASCIOLA HEPATICA; MUS; OVIS ARIES; POLYPODIUM LEUCOTOMOS; QUILLAJA SAPONARIA;

EID: 33947395298     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.12.017     Document Type: Article

References (28)

1. Almeida M.S., Torloni H., Lee-Ho P., Vilar M.M., Thaumaturgo N., Simpson A.J.G., and Tendler M. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen Sm14. Parasite Immunol. 25 (2003) 135-137
2. Arias M., Hillyer G.V., Sánchez-Andrade R., Suárez J.L., Pedreira J., Lomba C., Díaz P., Morrondo P., Díez-Baños P., and Paz-Silva A. A 2.9 kDa Fasciola hepatica-recombinant protein based ELISA test for the detection of current-ovine fasciolosis trickle infected. Vet. Parasitol. 137 (2006) 67-73
3. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Shellenbaum M., Van Orelli M., and Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 113 (1983) 315-317
4. Casanueva P., Hillyer G.V., Ramajo V., Oleaga A., Espinoza E.Y., and Muro A. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein. J. Parasitol. 87 (2001) 697-700
5. Esteves A., Joseph L., Paulino M., and Ehrlich E. Remarks on the phylogeny and structure of fatty acid binding proteins from parasitic platyhelminths. Int. J. Parasitol. 27 (1997) 1013-1023
6. Fairweather I., and Boray J.C. Fasciolicides: efficacy actions, resistance and its management. Vet. J. 158 (1999) 81-112
7. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 (1995) 1263-1276
8. Haroun E.T.M., and Hillyer G.V. Resistance to fascioliasis-a review. Vet. Parasitol. 20 (1986) 63-93
9. Hassan S., Maache M., Córdova O., Díaz de la Guardia R., Martins M., and Osuna A. Human secretory immune response to fatty acid binding protein fraction from Giardia lamblia. Infect. Immun. 70 (2002) 204-201
10. Hillyer G.V. Comparison of purified 12 kda and recombinant 15 kda Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein. Mem. Inst. Oswaldo Cruz. 90 (1995) 1-4
11. Hillyer G.V. Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J. Helminthol. 79 (2005) 1-8
12. Lee J.S., Kim I.S., Sohn W.M., Lee J., and Yong T.S. A DNA vaccine encoding a fatty acid-binding protein of Clonorchis sinensis induces protective immune response in Sprague-Dawley rats. Scand. J. Immunol. 63 (2006) 169-176
13. López-Abán, J., Nogal-Ruiz, J.J., Muñoz-Perea, B.C., Siles-Lucas, M., Martínez-Fernández, A.R., Muro, A., in press. Evaluation of a fasciolosis hyper-infection model in mice for vaccination trials. Revista Ibérica de Parasitología (in press).
14. López-Abán J., Oleaga A., Ramajo V., Casanueva P., Pérez Arellano J.L., Hillyer G.V., and Muro A. Vaccination of mice against Schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica. Vet. Parasitol. 91 (2000) 33-42
15. Maache M., Azzouz S., Diaz de la Guardia R., Alvarez P., Gil R., de Pablos L.M., and Osuna A. Host humoral immune response to Leishmania lipid-binding protein. Parasite Immunol. 27 (2005) 227-234
16. Martínez-Fernández A.R., Nogal-Ruiz J.J., López-Abán J., Ramajo V., Oleaga A., Manga-González Y., Hillyer G.V., and Muro A. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet. Parasitol. 126 (2004) 287-298
17. Mas-Coma S., Bargues M.D., and Valero M.A. Fascioliasis and other plant-borne trematode zoonoses. Int. J. Parasitol. 35 (2005) 1255-1278
18. Michalski M.L., Monsey J.D., Cistola D.P., and Weil G.J. An embryo-associated fatty acid-binding protein in the filarial nematode Brugia malayi. Mol. Biochem. Parasitol. 124 (2002) 1-10
19. Muro A., Ramajo V., López J., Simón F., and Hillyer G.V. Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Vet. Parasitol. 69 (1997) 219-229
20. Nambi P.A., Yadav S.C., Raina O.K., Sriveny D., and Saini M. Vaccination of buffaloes with Fasciola gigantica recombinant fatty acid binding protein. Parasitol. Res. 97 (2005) 129-135
21. Pérez J., Ortega J., Bravo A., Díez-Baños P., Morrondo P., Moreno T., and Martínez-Moreno A. Phenotype of hepatic infiltrates and hepatic lymph nodes of lambs primarily and challenge infected with Fasciola hepatica, with and without triclabendazole treatment. Vet. Res. 36 (2005) 1-12
22. Ramajo V., Oleaga A., Casanueva P., Hillyer G.V., and Muro A. Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins. Vet. Parasitol. 97 (2001) 35-46
23. Rodríguez-Pérez J., Rodrígue-Medina J.R., García-Blanco M., and Hillyer G.V. Fasciola hepatica: molecular cloning, nucleotide sequence and expression of a gen encoding a polypeptide homologous to Schistosoma mansoni fatty acid binding protein. Exp. Parasitol. 74 (1992) 400-407
24. Sánchez-Andrade R., Paz-Silva A., Suárez J.L., Panadero R., Pedreira I., Díez-Baños P., and Morrondo P. Effect of fasciolicides on the antigenaemia in sheep naturally infected with Fasciola hepatica. Parasitol. Res. 87 (2001) 609-614
25. Tendler M., Brito C.A., Vilar M.M., Serra-Freires N., Diogo C.M., Almeida M.S., Delbem C.B., da Silva J.F., Savino W., Garratt R.C., Katz N., and Simpson A.J.G. A Schistosoma mansoni fatty acid protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. 93 (1996) 269-273
26. Timanova A.M., Marti T., Walter R.D., and Bankov I.Y. Isolation and partial characterization of a fatty-acid-binding protein from Ascaris suum reproductive tissue. Parasitol. Res. 83 (1997) 518-521
27. Wijffels G.L., Salvatore L., Dosen M., Waddington J., Wilson L., Thompson C., Campbell N., Sexton J., Wicker J., Bowen F., Friedel R., and Spithill T.W. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity. Exp. Parasitol. 78 (1994) 132-148
28. Zimmerman A.W., and Veerkamp J.H. New insights into the structure and function of fatty acid-binding proteins. CMLS: Cell. Mol. Life Sci. 59 (2002) 1096-1116